The issue of drug shortages is a critical one and deserves a sober, evidence-based policy discussion by governments and experts. Generic drug manufacturing should not be nationalized for three reasons.
This pandemic, like the Spanish flu at the height of the Progressive era, is a chance for a burst of creativity in policy-making and a commitment to building new institutions.